These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 12828654)
1. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. Crotti T; Smith MD; Hirsch R; Soukoulis S; Weedon H; Capone M; Ahern MJ; Haynes D J Periodontal Res; 2003 Aug; 38(4):380-7. PubMed ID: 12828654 [TBL] [Abstract][Full Text] [Related]
2. Expression of receptor activator of NF-kappa B ligand and osteoprotegerin in culture of human periodontal ligament cells. Hasegawa T; Yoshimura Y; Kikuiri T; Yawaka Y; Takeyama S; Matsumoto A; Oguchi H; Shirakawa T J Periodontal Res; 2002 Dec; 37(6):405-11. PubMed ID: 12472833 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. Mogi M; Otogoto J; Ota N; Togari A J Dent Res; 2004 Feb; 83(2):166-9. PubMed ID: 14742657 [TBL] [Abstract][Full Text] [Related]
4. CSF-1, RANKL and OPG regulate osteoclastogenesis during murine tooth eruption. Heinrich J; Bsoul S; Barnes J; Woodruff K; Abboud S Arch Oral Biol; 2005 Oct; 50(10):897-908. PubMed ID: 16137499 [TBL] [Abstract][Full Text] [Related]
5. Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas. Kumamoto H; Ooya K J Oral Pathol Med; 2004 Jan; 33(1):46-52. PubMed ID: 14675140 [TBL] [Abstract][Full Text] [Related]
6. In situ expression of RANKL, RANK, osteoprotegerin and cytokines in osteoclasts of rat periodontal tissue. Ogasawara T; Yoshimine Y; Kiyoshima T; Kobayashi I; Matsuo K; Akamine A; Sakai H J Periodontal Res; 2004 Feb; 39(1):42-9. PubMed ID: 14687227 [TBL] [Abstract][Full Text] [Related]
7. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. Lu HK; Chen YL; Chang HC; Li CL; Kuo MY J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732 [TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii. Choi BK; Moon SY; Cha JH; Kim KW; Yoo YJ J Periodontol; 2005 May; 76(5):813-20. PubMed ID: 15898943 [TBL] [Abstract][Full Text] [Related]
9. Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. Oshiro T; Shiotani A; Shibasaki Y; Sasaki T Anat Rec; 2002 Apr; 266(4):218-25. PubMed ID: 11920384 [TBL] [Abstract][Full Text] [Related]
10. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750 [TBL] [Abstract][Full Text] [Related]
11. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Nagasawa T; Kobayashi H; Kiji M; Aramaki M; Mahanonda R; Kojima T; Murakami Y; Saito M; Morotome Y; Ishikawa I Clin Exp Immunol; 2002 Nov; 130(2):338-44. PubMed ID: 12390325 [TBL] [Abstract][Full Text] [Related]
12. The role of parathyroid hormone-related protein in the regulation of osteoclastogenesis by cementoblasts. Boabaid F; Berry JE; Koh AJ; Somerman MJ; McCcauley LK J Periodontol; 2004 Sep; 75(9):1247-54. PubMed ID: 15515341 [TBL] [Abstract][Full Text] [Related]
13. Immunolocalization of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) in Meckel's cartilage compared with developing endochondral bones in mice. Sakakura Y; Tsuruga E; Irie K; Hosokawa Y; Nakamura H; Yajima T J Anat; 2005 Oct; 207(4):325-37. PubMed ID: 16191162 [TBL] [Abstract][Full Text] [Related]
14. Osteoclastogenesis during mouse tooth germ development is mediated by receptor activator of NFKappa-B ligand (RANKL). Suzuki T; Suda N; Ohyama K J Bone Miner Metab; 2004; 22(3):185-91. PubMed ID: 15108059 [TBL] [Abstract][Full Text] [Related]
15. Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities. Wittrant Y; Theoleyre S; Couillaud S; Dunstan C; Heymann D; Rédini F Exp Cell Res; 2004 Feb; 293(2):292-301. PubMed ID: 14729467 [TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones. Swanson C; Lorentzon M; Conaway HH; Lerner UH Endocrinology; 2006 Jul; 147(7):3613-22. PubMed ID: 16614077 [TBL] [Abstract][Full Text] [Related]
17. Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Haynes DR; Barg E; Crotti TN; Holding C; Weedon H; Atkins GJ; Zannetino A; Ahern MJ; Coleman M; Roberts-Thomson PJ; Kraan M; Tak PP; Smith MD Rheumatology (Oxford); 2003 Jan; 42(1):123-34. PubMed ID: 12509625 [TBL] [Abstract][Full Text] [Related]
18. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644 [TBL] [Abstract][Full Text] [Related]
19. The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage. Komuro H; Olee T; Kühn K; Quach J; Brinson DC; Shikhman A; Valbracht J; Creighton-Achermann L; Lotz M Arthritis Rheum; 2001 Dec; 44(12):2768-76. PubMed ID: 11762937 [TBL] [Abstract][Full Text] [Related]
20. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Liu D; Xu JK; Figliomeni L; Huang L; Pavlos NJ; Rogers M; Tan A; Price P; Zheng MH Int J Mol Med; 2003 Jan; 11(1):17-21. PubMed ID: 12469211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]